[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  BioMedWire [@BioMedWire](/creator/twitter/BioMedWire) on x 1297 followers Created: 2025-07-24 18:00:18 UTC $AZN new immune disorder treatment shows success in late-stage trials, offering hope for patients with rare conditions. A major step forward in targeted therapies: #AstraZeneca #ImmuneHealth #RareDiseases #BiotechNews #ClinicalTrials  XX engagements  **Related Topics** [azn astrazeneca](/topic/azn-astrazeneca) [manat](/topic/manat) [$azn](/topic/$azn) [stocks healthcare](/topic/stocks-healthcare) [Post Link](https://x.com/BioMedWire/status/1948443135115182458)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
BioMedWire @BioMedWire on x 1297 followers
Created: 2025-07-24 18:00:18 UTC
$AZN new immune disorder treatment shows success in late-stage trials, offering hope for patients with rare conditions. A major step forward in targeted therapies:
#AstraZeneca #ImmuneHealth #RareDiseases #BiotechNews #ClinicalTrials
XX engagements
Related Topics azn astrazeneca manat $azn stocks healthcare
/post/tweet::1948443135115182458